Principal Financial Group Inc. Grows Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Principal Financial Group Inc. raised its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 9.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 43,960 shares of the company’s stock after buying an additional 3,874 shares during the quarter. Principal Financial Group Inc.’s holdings in Definitive Healthcare were worth $181,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Rhumbline Advisers increased its holdings in Definitive Healthcare by 5.2% in the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock worth $334,000 after buying an additional 4,034 shares during the period. Glenmede Trust Co. NA increased its holdings in Definitive Healthcare by 41.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares during the period. Nisa Investment Advisors LLC increased its holdings in Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after buying an additional 6,794 shares during the period. Point72 DIFC Ltd increased its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after buying an additional 8,215 shares during the period. Finally, SG Americas Securities LLC increased its holdings in Definitive Healthcare by 44.6% in the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after buying an additional 8,387 shares during the period. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Trading Up 8.4 %

Shares of DH opened at $2.85 on Friday. Definitive Healthcare Corp. has a 52-week low of $2.58 and a 52-week high of $8.71. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm’s fifty day moving average is $4.49 and its two-hundred day moving average is $4.43. The stock has a market cap of $321.80 million, a PE ratio of -0.92, a price-to-earnings-growth ratio of 4.06 and a beta of 1.51.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. Research analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DH has been the topic of several research reports. The Goldman Sachs Group cut their price target on shares of Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Stephens assumed coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price for the company. Barclays cut their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating for the company in a report on Monday, March 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, Definitive Healthcare currently has an average rating of “Hold” and an average target price of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.